Are serotonin 3A and 3B receptor genes associated with suicidal behavior in schizophrenia subjects?

Neuroscience Letters

Volumn 489, Issue 3, 2011, Pages 137-141

  Souza, Renan P ^a,b,d   De Luca, Vincenzo ^a,b   Manchia, Mirko ^c   Kennedy, James L ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Gene gene interaction; Haplotype; HELIX TREE; Multidimensional reduction

Indexed keywords

SEROTONIN 3A RECEPTOR; SEROTONIN 3B RECEPTOR;

ADULT; ARTICLE; CHROMOSOME 11Q; DNA POLYMORPHISM; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SUICIDAL BEHAVIOR;

ADULT; ALLELES; EPISTASIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, SEROTONIN, 5-HT3; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUICIDE;

EID: 78751569547     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.11.079     Document Type: Article

References (32)

1. Adler L.E., Cawthra E.M., Donovan K.A., Harris J.G., Nagamoto H.T., Olincy A., Waldo M.C. Improved p50 auditory gating with ondansetron in medicated schizophrenia patients. Am. J. Psychiatry 2005, 162:386-388.
2. Akhondzadeh S., Mohammadi N., Noroozian M., Karamghadiri N., Ghoreishi A., Jamshidi A.H., Forghani S. Added ondansetron for stable schizophrenia: a double blind, placebo controlled trial. Schizophr. Res. 2008.
3. Asberg M., Traskman L., Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?. Arch. Gen. Psychiatry 1976, 33:1193-1197.
4. Asberg M. Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Ann. N.Y. Acad. Sci. 1997, 836:158-181.
5. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
6. Boone C., Bussey H., Andrews B.J. Exploring genetic interactions and networks with yeast. Nat. Rev. Genet. 2007, 8:437-449.
7. Carlborg A., Jokinen J., Nordstrom A.L., Jonsson E.G., Nordstrom P. CSF 5-HIAA, attempted suicide and suicide risk in schizophrenia spectrum psychosis. Schizophr. Res. 2009, 112:80-85.
8. Courtet P., Jollant F., Castelnau D., Buresi C., Malafosse A. Suicidal behavior: relationship between phenotype and serotonergic genotype. Am. J. Med. Genet. C: Semin. Med. Genet. 2005, 133:25-33.
9. Davies P.A., Pistis M., Hanna M.C., Peters J.A., Lambert J.J., Hales T.G., Kirkness E.F. The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature 1999, 397:359-363.
10. Frank B., Niesler B., Nothen M.M., Neidt H., Propping P., Bondy B., Rietschel M., Maier W., Albus M., Rappold G. Investigation of the human serotonin receptor gene HTR3B in bipolar affective and schizophrenic patients. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2004, 131:1-5.
11. Gutierrez B., Arranz M.J., Huezo-Diaz P., Dempster D., Matthiasson P., Travis M., Munro J., Osborne S., Kerwin R.W. Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response. Schizophr. Res. 2002, 58:93-97.
12. Ji X., Takahashi N., Saito S., Ishihara R., Maeno N., Inada T., Ozaki N. Relationship between three serotonin receptor subtypes (HTR3A, HTR2A and HTR4) and treatment-resistant schizophrenia in the Japanese population. Neurosci. Lett. 2008, 435:95-98.
13. Ji X., Takahashi N., Branko A., Ishihara R., Nagai T., Mouri A., Saito S., Maeno N., Inada T., Ozaki N. An association between serotonin receptor 3B gene (HTR3B) and treatment-resistant schizophrenia (TRS) in a Japanese population. Nagoya J. Med. Sci. 2008, 70:11-17.
14. Kelley S.P., Dunlop J.I., Kirkness E.F., Lambert J.J., Peters J.A. A cytoplasmic region determines single-channel conductance in 5-HT3 receptors. Nature 2003, 424:321-324.
15. Kerwin R.W., Bolonna A.A. Is clozapine antisuicidal?. Expert Rev. Neurother. 2004, 4:187-190.
16. Malkesman O., Pine D.S., Tragon T., Austin D.R., Henter I.D., Chen G., Manji H.K. Animal models of suicide-trait-related behaviors. Trends Pharmacol. Sci. 2009, 30:165-173.
17. Mann J.J., Arango V., Henteleff R.A., Lagattuta T.F., Wong D.T. Serotonin 5-HT3 receptor binding kinetics in the cortex of suicide victims are normal. J. Neural Transm. 1996, 103:165-171.
18. Meltzer H.Y., Alphs L., Green A.I., Altamura A.C., Anand R., Bertoldi A., Bourgeois M., Chouinard G., Islam M.Z., Kane J., Krishnan R., Lindenmayer J.P., Potkin S. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch. Gen. Psychiatry 2003, 60:82-91.
19. Moore J.H., Gilbert J.C., Tsai C.T., Chiang F.T., Holden T., Barney N., White B.C. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J. Theor. Biol. 2006, 241:252-261.
20. Niesler B., Frank B., Kapeller J., Rappold G.A. Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene 2003, 310:101-111.
21. Niesler B., Weiss B., Fischer C., Nothen M.M., Propping P., Bondy B., Rietschel M., Maier W., Albus M., Franzek E., Rappold G.A. Serotonin receptor gene HTR3A variants in schizophrenic and bipolar affective patients. Pharmacogenetics 2001, 11:21-27.
22. Pandey G.N., Pandey S.C., Dwivedi Y., Sharma R.P., Janicak P.G., Davis J.M. Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior. Am. J. Psychiatry 1995, 152:850-855.
23. Phillips P.C. Epistasis - the essential role of gene interactions in the structure and evolution of genetic systems. Nat. Rev. Genet. 2008, 9:855-867.
24. Powell J., Geddes J., Deeks J., Goldacre M., Hawton K. Suicide in psychiatric hospital in-patients. Risk factors and their predictive power. Br. J. Psychiatry 2000, 176:266-272.
25. Roy A., Nielsen D., Rylander G., Sarchiapone M., Segal N. Genetics of suicide in depression. J. Clin. Psychiatry 1999, 60(Suppl. 2):12-17.
26. Sirota P., Mosheva T., Shabtai H., Korczyn A.D. Treating tardive dyskinesia with ondansetron. J. Clin. Psychopharmacol. 2001, 21:355-356.
27. Souza R.P., Romano-Silva M.A., Lieberman J.A., Meltzer H.Y., Macneil L.T., Culotti J.G., Kennedy J.L., Wong A.H. Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response. J. Psychiatr. Res. 2010, 44:700-706.
28. Souza R.P., de Luca V., Meltzer H.Y., Lieberman J.A., Kennedy J.L. Influence of serotonin 3A and 3B receptor genes on clozapine treatment response in schizophrenia. Pharmacogenet. Genomics 2010, 20:274-276.
29. Souza R.P., Romano-Silva M.A., Lieberman J.A., Meltzer H.Y., Wong A.H., Kennedy J.L. Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response. Psychopharmacology (Berlin) 2008, 200:177-186.
30. White A., Corn T.H., Feetham C., Faulconbridge C. Ondansetron in treatment of schizophrenia. Lancet 1991, 337:1173.
31. Yamada K., Hattori E., Iwayama Y., Ohnishi T., Ohba H., Toyota T., Takao H., Minabe Y., Nakatani N., Higuchi T., tera-Wadleigh S.D., Yoshikawa T. Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression. Biol. Psychiatry 2006, 60:192-201.
32. Zhang Z.J., Kang W.H., Li Q., Wang X.Y., Yao S.M., Ma A.Q. Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: a double-blind, randomized, placebo-controlled study. Schizophr. Res. 2006, 88:102-110.